|
Re: Apabetalone inhibits kidney damage in diabetes
|
2
|
Resverlogix Corp.
|
Aug 22, 2024 12:07PM
|
|
Re: Apabetalone inhibits kidney damage in diabetes
|
2
|
Resverlogix Corp.
|
Aug 23, 2024 12:13PM
|
|
Re: Another Week
|
2
|
Resverlogix Corp.
|
Oct 21, 2022 04:08PM
|
|
Re: AGM Voting
|
4
|
Zenith Epigenetics
|
Oct 17, 2022 03:54PM
|
|
Re: Additional Reports Of Exempt Distribution.
|
5
|
Zenith Epigenetics
|
Jun 06, 2024 11:25AM
|
|
Re: Add one to the list
|
3
|
Zenith Epigenetics
|
Sep 13, 2023 11:47AM
|
|
Re: A Special Meeting of Shareholders?
|
3
|
Resverlogix Corp.
|
May 29, 2024 11:56AM
|
|
Re: A Special Meeting of Shareholders?
|
1
|
Resverlogix Corp.
|
May 29, 2024 12:25PM
|
|
Re: A Special Meeting of Shareholders?
|
2
|
Resverlogix Corp.
|
May 30, 2024 04:35PM
|
|
Re: 2 year extension
|
5
|
Resverlogix Corp.
|
May 13, 2024 05:11PM
|
|
Presentation
|
5
|
Resverlogix Corp.
|
Aug 01, 2024 03:50PM
|
|
Possibility?
|
1
|
Resverlogix Corp.
|
May 07, 2024 09:30AM
|
|
Phase 1B in TNBC suspended
|
1
|
Zenith Epigenetics
|
May 23, 2024 07:18PM
|
|
New SEDAR page
|
4
|
Zenith Epigenetics
|
Aug 02, 2023 02:29PM
|
|
New Phase 2 Trial
|
8
|
Zenith Epigenetics
|
Jan 03, 2023 02:03PM
|
|
New Phase 1 NCI trial
|
7
|
Zenith Epigenetics
|
May 24, 2023 05:43PM
|
|
NCT05372640
|
4
|
Zenith Epigenetics
|
Sep 12, 2023 11:47AM
|
|
Link to 2023 AGM presentation is up
|
2
|
Resverlogix Corp.
|
Jun 21, 2023 01:22PM
|
|
Expert market
|
1
|
Zenith Epigenetics
|
Sep 18, 2024 02:09PM
|
|
Dr. Wong retires - Dr. Kulikowski in as CSO
|
4
|
Resverlogix Corp.
|
Aug 15, 2022 06:08PM
|
